Form 8-K - Current report:
SEC Accession No. 0000950170-22-018514
Filing Date
2022-09-15
Accepted
2022-09-15 06:33:26
Documents
19
Period of Report
2022-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20220912.htm   iXBRL 8-K 65259
2 EX-1.1 rlay-ex1_1.htm EX-1.1 441415
3 EX-5.1 rlay-ex5_1.htm EX-5.1 18770
4 EX-99.1 rlay-ex99_1.htm EX-99.1 14860
5 EX-99.2 rlay-ex99_2.htm EX-99.2 14382
6 GRAPHIC img142084332_0.jpg GRAPHIC 25886
7 GRAPHIC img175089203_0.jpg GRAPHIC 7368
8 GRAPHIC img176012724_0.jpg GRAPHIC 7368
  Complete submission text file 0000950170-22-018514.txt   807142

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20220912_pre.xml EX-101.PRE 9443
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20220912.xsd EX-101.SCH 2454
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20220912_lab.xml EX-101.LAB 12806
13 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20220912_htm.xml XML 4526
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 221244461
SIC: 2836 Biological Products, (No Diagnostic Substances)